NEWS
>
Press Releases
March 10, 2008 - Pharmexa and Ichor Medical Systems Enter into an Agreement to Co-develop Multiple DNA Vaccines Delivered by Electroporation
View Release
March 4, 2008 - Ichor Melanoma Vaccine Clinical Trial Moves to the Highest Dose Level
View Release
October 1, 2007 - Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine
View Release
August 6, 2007 - Navy Partners with Ichor Medical Systems to Develop a Vaccine for Anthrax and Plague
View Release
June 18, 2007 - Ichor Medical Systems Selects Gable PR
View Release
May 14, 2007 - FDA Approves Phase I Clinical Trial Using Ichor's TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering
View Release
March 26, 2007 - Interferon Beta DNA Treatment Delivered with Ichor Technology Reduces Atherosclerosis Progression in Mice
View Release
March 5, 2007 - United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
View Release
December 18, 2006 - Pharmexa-Epimmune and Ichor Medical Systems Enter into a Collaborative Agreement
View Release
August 24, 2005 - Ichor Medical Systems Awarded Key Electroporation Patent
View Release
June 28, 2005 - Ichor Medical Systems Settlement Agreement Approved
View Release
September 4, 2003 - Ichor Medical Systems, Inc. Secures Rights to Interleukin-12 from The Wistar Institute
View Release
June 12, 2003 - Ichor Medical Systems Prevails in Equitable Assignment Judgment
View Release
May 14, 2003 - Ichor Medical Systems Awarded $13.5 Million in "Pivotal" Intellectual Property Verdict
View Release